7 Stocks to Buy NOW in the Trillion💲Weight Loss Boom

Weight loss drug stocks have boomed with both up 30% this year and triple-digit potential to come. 🤑 FREE weekly newsletter sharing market updates, trends and the most important news! https://mystockmarketbasics.com/dailybowtie We are just recently seeing legit weight loss drugs helping people drop hundreds of pounds. It’s not a replacement for a healthy diet and exercise but for millions of people, it could be hope to get them started. A Wall Street analyst at Bank of America believes peak sales for weight loss drugs could hit $100 billion a year by 2030 , almost five-times the peak sales for Humira, the best-selling drug in history! That’s a trillion-dollar market opportunity and I’ve found seven weight loss drug stocks that could boom! Don’t miss these other videos for stocks to buy right now! ✅ 9 Stocks that Could Save Your LIFE! https://youtu.be/p2fxeH-o68U ✅ How to Invest $1000 to 10X your Money in 2023 https://youtu.be/BxlFf58Q1GA Drug stocks with the first two weight loss drugs have jumped over the last year with one up more than 100% return. There are 764 million people globally struggling with obesity and these new weight loss drugs have helped patients reduce body weight by 15% and more. The market potential for companies selling these could easily be $100 billion a year and considering most drug stocks report less than $30 billion a year in total revenue, just a fraction of this market could boost sales and the stock price. The two early winners here are Eli Lilly, LLY, with its Mounjaro brand, and Novo Nordisk, NVO, with the popular Ozempic drug but the stock prices have already boomed higher. The market has already caught on to the potential here and shares of Lilly are trading at nosebleed valuations. The stock is priced at 68-times earnings, a 36% premium to its five-year average which is also extremely high. For comparison, the SPDR S&P Pharmaceuticals ETF, a fund of the 39 largest drug stocks, trades at just 15-times price-to-earnings, less than a fourth the valuation. That's why I wanted to highlight five other stocks to watch in this weight loss drug stock theme, five companies that could also benefit for higher returns. I'll reveal two other drug stocks with potential weight loss candidates in testing along with two stocks that will benefit from the increase in weight management and prescriptions. Then I'll show you a penny stock that could 10X your money on its own weight loss drug. Join the Community for extra perks and access! Check out these member extras ✅ Instant Buy/Sell Notifications and Stock Ideas ✅ Stock Split and IPO Alerts ✅ Monthly Live Q&A ✅ ...MORE! https://mystockmarketbasics.com/BowTieMember 🤑 Get The Weekly Bow-Tie - my FREE weekly email newsletter sharing market updates, trends and the most important news! Market Updates for the Smart Investor! https://mystockmarketbasics.com/dailybowtie My Investing Recommendations 📈 Check out the stock simulator and Get six FREE shares of stock worth up to $10,000 when you open a Webull investing account with any deposit! 🤑 https://mystockmarketbasics.com/webull 📊 Download this Portfolio Tracker and Investing Spreadsheet! [Community Discount Code] https://mystockmarketbasics.com/spreadsheetdiscount ✅ FREE Report! See the top five stocks in my portfolio, the five stocks I'm buying for the next 30 years! https://mystockmarketbasics.com/motleyfool ✅ Save $120 and get 50% off Premium Access to the largest investment analysis community in the world! Lowest price online for Seeking Alpha premium access! https://mystockmarketbasics.com/SeekingAlphaDiscount Joseph Hogue, CFA spent nearly a decade as an investment analyst for institutional firms and banks. He now helps people understand their financial lives through debt payoff strategies, investing and ways to save more money. He has appeared on Bloomberg and on sites like CNBC and Morningstar. He holds the Chartered Financial Analyst (CFA) designation and is a veteran of the Marine Corps. #stockstobuy #stockstowatch #stocks